Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc.
| -10.86K |
$13.65 | -$934,659.31 | -1.16% | 927.01K |
Jan 9 - Jan 10
| |||||||
Amicus Therapeutics, Inc.
| -29.18K |
$13.35 | -$389,543.01 | -4.84% | 573.48K |
Mar 1
| |||||||
Amicus Therapeutics, Inc.
| -126.58K |
$13.95 | -$1,766,117.40 | -17.36% | 602.66K |
Feb 15
| |||||||
Amicus Therapeutics, Inc.
| -53.21K |
$12.64 | -$672,539.42 | -6.80% | 729.24K |
Feb 1
| |||||||
Amicus Therapeutics, Inc.
| -55.33K |
$12.36 | -$683,957.91 | -6.60% | 782.45K |
Jan 22
| |||||||
Amicus Therapeutics, Inc.
| -31.61K |
$12.78 | -$404,105.95 | -3.64% | 837.78K |
Jan 16
| |||||||
Amicus Therapeutics, Inc.
| -68.48K |
$13.65 | -$934,659.31 | -7.30% | 869.39K |
Jan 9 - Jan 10
| |||||||
Amicus Therapeutics, Inc.
| -10.66K |
$13.44 | -$143,256.96 | -1.12% | 937.87K |
Jan 4
| |||||||
Amicus Therapeutics, Inc.
| 36.21K |
$13.53 | -$1,466,882.01 | +3.97% | 948.53K |
Jan 2 - Jan 3
| |||||||
Amicus Therapeutics, Inc.
| 28.53K |
$12.66 | -$76,515.86 | +3.23% | 912.32K |
Dec 15 - Dec 18
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.08 | -$66,956.44 | -0.68% | 883.79K |
Dec 1
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$10.84 | -$65,497.06 | -0.67% | 889.83K |
Nov 15
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$10.97 | -$66,327.46 | -0.67% | 895.88K |
Nov 1
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$10.50 | -$63,449.31 | -0.67% | 901.92K |
Oct 16
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.25 | -$67,967.08 | -0.66% | 907.97K |
Oct 2
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$13.06 | -$78,963.65 | -0.66% | 914.01K |
Sep 15
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$12.98 | -$78,447.49 | -0.65% | 920.05K |
Sep 1
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$13.03 | -$78,733.98 | -0.65% | 926.1K |
Aug 15
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$13.35 | -$80,716.41 | -0.64% | 932.14K |
Aug 1
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$13.45 | -$81,263.39 | -0.64% | 938.18K |
Jul 17
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$12.31 | -$74,405.87 | -0.64% | 944.23K |
Jul 3
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$13.04 | -$78,813.76 | -0.63% | 950.27K |
Jun 15
| |||||||
Intellia Therapeutics, Inc.
| 4.42K |
—
|
—
| +60.69% | 11.72K |
Jun 14
| |||||||
Entrada Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.36 | -$68,657.42 | -0.63% | 956.32K |
Jun 1
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.18 | -$67,576.76 | -0.62% | 962.36K |
May 15
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.80 | -$71,334.91 | -0.62% | 968.4K |
May 1
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.66 | -$70,502.05 | -0.62% | 974.45K |
Apr 17
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.22 | -$67,787.09 | -0.61% | 980.49K |
Apr 3
| |||||||
Amicus Therapeutics, Inc.
| -6.04K |
$11.34 | -$68,547.42 | -0.61% | 986.54K |
Mar 15
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| -6.04K |
$13.42 | -$81,093.02 | -0.61% | 992.58K |
Mar 1
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| -6.04K |
$12.94 | -$78,217.22 | -0.60% | 1M |
Feb 15
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| -7.39K |
$9.41 | -$1,132,673.44 | -0.73% | 1M |
Feb 1
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| 126.83K |
$12.02 | -$1,000,797.22 | +14.33% | 1.01M |
Jan 11
| |||||||
Amicus Therapeutics, Inc.
| -85.10K |
$11.43 | -$972,954.15 | -8.77% | 885.23K |
Jan 9
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| -10.66K |
$12.03 | -$128,227.77 | -1.09% | 970.33K |
Jan 4
| |||||||
Amicus Therapeutics, Inc.
| 189.54K |
$12.07 | -$527,531.04 | +23.95% | 980.99K |
Jan 2 - Jan 3
| |||||||
Amicus Therapeutics, Inc.
| -10.47K |
$12.15 | -$127,171.54 | -1.31% | 791.45K |
Dec 15
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| -11.35K |
$12.20 | -$138,473.11 | -1.40% | 801.92K |
Dec 1
|
Scheduled
| ||||||
Amicus Therapeutics, Inc.
| -10.47K |
$11.64 | -$121,866.36 | -1.27% | 813.27K |
Nov 15
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.